Credit Suisse’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $15.7M | Sell |
85,380
-9,969
| -10% | -$1.9M | 0.02% | 715 |
|
|
2023
Q4 | $17.1M | Buy |
95,349
+4,368
| +5% | +$680K | 0.02% | 705 |
|
|
2023
Q3 | $14.5M | Sell |
90,981
-778
| -0.8% | -$127K | 0.01% | 746 |
|
|
2023
Q2 | $13M | Buy |
91,759
+49,635
| +118% | +$7.96M | 0.01% | 813 |
|
|
2023
Q1 | $7.09M | Sell |
42,124
-139
| -0.3% | -$24.8K | 0.01% | 1099 |
|
|
2022
Q4 | $7.16M | Sell |
42,263
-10,314
| -20% | -$1.87M | 0.01% | 1086 |
|
|
2022
Q3 | $9.84M | Buy |
52,577
+758
| +1% | +$160K | 0.01% | 909 |
|
|
2022
Q2 | $8.42M | Sell |
51,819
-1,366
| -3% | -$216K | 0.01% | 1006 |
|
|
2022
Q1 | $10M | Buy |
53,185
+2,937
| +6% | +$558K | 0.01% | 1048 |
|
|
2021
Q4 | $13.3M | Sell |
50,248
-10,786
| -18% | -$2.91M | 0.01% | 1304 |
|
|
2021
Q3 | $17.6M | Buy |
61,034
+4,109
| +7% | +$1.05M | 0.01% | 1152 |
|
|
2021
Q2 | $11.4M | Buy |
56,925
+879
| +2% | +$171K | 0.01% | 1476 |
|
|
2021
Q1 | $10.9M | Buy |
56,046
+1,755
| +3% | +$360K | 0.01% | 1528 |
|
|
2020
Q4 | $10.4M | Sell |
54,291
-16,262
| -23% | -$2.96M | 0.01% | 1548 |
|
|
2020
Q3 | $10.4M | Buy |
70,553
+4,141
| +6% | +$592K | 0.01% | 1362 |
|
|
2020
Q2 | $8.21M | Buy |
66,412
+26,279
| +65% | +$3.09M | 0.01% | 1403 |
|
|
2020
Q1 | $3.88M | Sell |
40,133
-1,318
| -3% | -$127K | ﹤0.01% | 1701 |
|
|
2019
Q4 | $3.83M | Sell |
41,451
-26,152
| -39% | -$2.2M | ﹤0.01% | 2070 |
|
|
2019
Q3 | $5.18M | Buy |
67,603
+43,574
| +181% | +$3.81M | ﹤0.01% | 1737 |
|
|
2019
Q2 | $2.06M | Sell |
24,029
-65,874
| -73% | -$4.49M | ﹤0.01% | 2424 |
|
|
2019
Q1 | $5.31M | Buy |
89,903
+22,296
| +33% | +$1.28M | ﹤0.01% | 1674 |
|
|
2018
Q4 | $3.56M | Buy |
67,607
+38,819
| +135% | +$2.28M | ﹤0.01% | 1833 |
|
|
2018
Q3 | $1.6M | Sell |
28,788
-6,611
| -19% | -$341K | ﹤0.01% | 2524 |
|
|
2018
Q2 | $1.67M | Sell |
35,399
-5,244
| -13% | -$216K | ﹤0.01% | 2613 |
|
|
2018
Q1 | $1.47M | Buy |
40,643
+6,966
| +21% | +$245K | ﹤0.01% | 2673 |
|
|
2017
Q4 | $1.22M | Sell |
33,677
-61,145
| -64% | -$2.21M | ﹤0.01% | 2849 |
|
|
2017
Q3 | $3.63M | Sell |
94,822
-20,207
| -18% | -$847K | ﹤0.01% | 2028 |
|
|
2017
Q2 | $4.77M | Buy |
115,029
+43,349
| +60% | +$1.65M | ﹤0.01% | 1657 |
|
|
2017
Q1 | $2.52M | Buy |
71,680
+6,551
| +10% | +$207K | ﹤0.01% | 2179 |
|
|
2016
Q4 | $2.01M | Buy |
65,129
+8,736
| +15% | +$270K | ﹤0.01% | 2440 |
|
|
2016
Q3 | $1.7M | Buy |
56,393
+274
| +0.5% | +$8.27K | ﹤0.01% | 2506 |
|
|
2016
Q2 | $1.53M | Buy |
56,119
+24,185
| +76% | +$618K | ﹤0.01% | 2551 |
|
|
2016
Q1 | $856K | Buy |
31,934
+5,478
| +21% | +$134K | ﹤0.01% | 2844 |
|
|
2015
Q4 | $748K | Buy |
26,456
+5,879
| +29% | +$170K | ﹤0.01% | 3058 |
|
|
2015
Q3 | $572K | Sell |
20,577
-49,530
| -71% | -$1.79M | ﹤0.01% | 3299 |
|
|
2015
Q2 | $2.89M | Buy |
70,107
+25,685
| +58% | +$941K | ﹤0.01% | 2243 |
|
|
2015
Q1 | $1.35M | Sell |
44,422
-16,663
| -27% | -$432K | ﹤0.01% | 2734 |
|
|
2014
Q4 | $1.21M | Buy |
61,085
+7,273
| +14% | +$163K | ﹤0.01% | 2976 |
|
|
2014
Q3 | $1.07M | Buy |
53,812
+30,460
| +130% | +$641K | ﹤0.01% | 2986 |
|
|
2014
Q2 | $532K | Sell |
23,352
-95,726
| -80% | -$1.7M | ﹤0.01% | 3785 |
|
|
2014
Q1 | $1.53M | Buy |
119,078
+7,844
| +7% | +$112K | ﹤0.01% | 2739 |
|
|
2013
Q4 | $1.52M | Buy |
111,234
+19,394
| +21% | +$232K | ﹤0.01% | 2918 |
|
|
2013
Q3 | $1.02M | Buy |
91,840
+37,100
| +68% | +$369K | ﹤0.01% | 2944 |
|
|
2013
Q2 | $451K | Buy |
+54,740
| New | +$460K | ﹤0.01% | 3377 |
|
Other funds holding RGEN
BCM
Credit Suisse's RGEN Position: Q1 2024 in Review
Credit Suisse reduced its Repligen (RGEN) stake by 10% in Q1 2024, selling an estimated $1.9M and leaving 85,380 shares worth $15.7M. The position accounts for 0.02% of the portfolio, ranked #715.
Credit Suisse first reported a position in RGEN in Q2 2013 and has held it in 44 quarters since. The position peaked at $17.6M in Q3 2021. 486 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.
- Credit Suisse held 85,380 shares of Repligen worth $15.7M as of Q1 2024.
- Credit Suisse sold 9,969 Repligen shares in Q1 2024, an estimated $1.9M.
- Repligen made up 0.02% of Credit Suisse's portfolio in Q1 2024, its #715 holding.
- Credit Suisse first reported a position in Repligen in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Repligen position peaked at $17.6M in Q3 2021.
- 486 funds tracked by Wall St. Rank held Repligen as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.